SPONSOR
Tasly Pharmaceutical Group Co., Ltd
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 3, Phase 1, Phase 2, Phase 2
Conditions studied: Heart FailureCommon ColdRecurrent Glioblastoma IDH WildtypeCoronary Artery Bypass Grafting (CABG)Chronic Heart FailureChronic Ischemic CardiomyopathyPlaque Psoriasis
Tasly Pharmaceutical Group Co., Ltd is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Heart Failure, Common Cold, Recurrent Glioblastoma IDH Wildtype, Coronary Artery Bypass Grafting (CABG).
The trial portfolio spans Phase 1, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tasly Pharmaceutical Group Co., Ltd
How many clinical trials has Tasly Pharmaceutical Group Co., Ltd sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Tasly Pharmaceutical Group Co., Ltd, of which 5 are actively recruiting participants. These trials cover conditions including Heart Failure, Common Cold, Recurrent Glioblastoma IDH Wildtype. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tasly Pharmaceutical Group Co., Ltd research focus on?
Tasly Pharmaceutical Group Co., Ltd clinical trials span Heart Failure, Common Cold, Recurrent Glioblastoma IDH Wildtype, Coronary Artery Bypass Grafting (CABG), Chronic Heart Failure, and additional conditions. The research pipeline includes Phase 1, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tasly Pharmaceutical Group Co., Ltd clinical trial?
To participate in a Tasly Pharmaceutical Group Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tasly Pharmaceutical Group Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Tasly Pharmaceutical Group Co., Ltd
NCT06348498 Phase 1
Recruiting
Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure
Heart Failure
NCT06697886 Phase 3
Recruiting
A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold
Common Cold
NCT07318818 Phase 1, Phase 2
Recruiting
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
Recurrent Glioblastoma IDH Wildtype
NCT07265349 Phase 1, Phase 2
Recruiting
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
Coronary Artery Bypass Grafting (CABG)
NCT06058546 Phase 2
Recruiting
Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
Plaque Psoriasis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology